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ABSTRACT 
 
 
Ion channels play a critical role in maintaining homeostasis by moving various ions in 
and out of cells. The Na
+
-K
+
-2Cl
-
 or NKCC1 ion channel is involved in the regulation of Na
+
, 
K
+
, and Cl
-
 across cell membranes, and plays a key role in many forms of cellular physiology. In 
the cochlea, NKCC1 is involved in endolymph production and maintenance of the endocochlear 
potential. Our hypothesis is that blocking NKCC1 channels should directly impact auditory 
sensitivity causing hearing loss. Our lab has also shown that the hormone aldosterone (ALD) can 
upregulate NKCC1 protein expression in vitro and in vivo. In the present investigation, we use 
electrophysiology and molecular biology techniques to study the biophysical mechanisms 
underlying the action of ALD in vitro on NKCC1 in the SH-SY5Y cell line. Our initial protein 
expression studies using RT-PCR found that proteins specific to NKCC1channels were present 
in SH-SY5Y neuronal cells. Whole cell currents measured using patch clamp methodology, were 
used to analyze the effects of various compounds on NKCC1 in the SH-SY5Y cell line. Control 
data were collected under perfusion of extracellular solution (ECS), then ECS containing 10µM 
bumetanide was applied, and, finally a washout condition completed the experiment. Similar 
experiments were conducted using ALD, and we observed an increase in K
+
 currents when 
bumetanide as well as when ALD was applied. This is the first report that indicates that ALD can 
directly regulate K
+
 channels in SH-SY5Y cells. 
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CHAPTER 1: 
INTRODUCTION AND BACKGROUND 
 
1.1 NKCC1 and its Role in Inner Ear Function       
           As people get older, they lose their hearing ability. Apart from normal aging there are a 
number of other factors which contribute to this age-related hearing loss (ARHL). Recently, Na
+
-
K
+
-2Cl
-
 co-transport protein (NKCC1) activity was shown to be involved in age-related hearing 
loss [1]. Na
+
/K
+
/Cl
-
 co-transporters are members of the electroneutral cation-chloride 
cotransporter family with two isoforms, the secretory isoform and absorptive isoform found in 
exocrine epithelia and the renal thick ascending limb of Henle’s loop, respectively [2]. In the 
plasma membrane, NKCC1 exists as an oligomer and the dominant structural unit of NKCC1 is a 
homodimer of 355kDa  [3].  NKCC1 carries out many vital functions in organs such as kidney, 
brain and cochlea. For instance, NKCC1 has key a role in reducing GABAergic inhibition in 
spontaneously hypertensive rats through chloride homeostasis disruption [4]. Low intracellular 
Cl
-
 ion concentration and protein phosphatase inhibition promotes phosphorylation of NKCC1 
and thus activates it. In addition, NKCC1 transports chloride ions into the cell, driven 
energetically across the membrane because of gradients between Na
+
 and/or K
+
 and Cl
-
 ions [5].  
   The population with ARHL continues to grow, as the “Baby Boomers” reach retirement 
ages, and understanding the underlying mechanisms of age-related changes in cochlear function 
will be key for developing potential therapies. ARHL occurrence can be altered via both 
genetically inherited traits and also by exposure to loud noise or ototoxic drugs [6, 7]. 
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Schuknecht classified ARHL into four types i.e., sensory, neural, cochlear-conductive and strial. 
Strial ARHL occurs due to degeneration of the  stria vascularis, which is a specialized organ 
located on the lateral wall of the cochlear scala media [8, 9].  Age-linked stria vascularis 
degeneration has been associated as a primary cause of presbycusis or ARHL [8, 9].  
       The endocochlear potential (EP) is the voltage difference established by cells in the  stria 
vascularis and is crucial for the normal functioning of inner ear receptor cells [10]. A high resting 
EP is established due to high K
+
 and low Na
+
 concentration in endolymph [6]. Application of the  
NKCC1 antagonist furosemide decreases the EP and also elevates the thresholds of auditory 
nerve fibers [11]. The EP declines with age, and in addition down regulation or inactivation of 
NKCC1 membrane proteins causes decreases in EP. Therefore it’s evident that NKCC1 plays a 
crucial role in ARHL. When an acoustic stimulus reaches stereocilia of the inner ear, K
+
 ions are 
transported from endolymph into the hair cell, causing depolarization of the hair cell membrane. 
Electrical signals generated following depolarization are transported to the brain through the 
auditory nerve [12]. In stria marginal cells of the cochlea, NKCC1 participates in production of a 
potassium-rich endolymphatic fluid [1]. Decreases in endolymph K
+
 concentration leads to 
significant hearing deficits, which indicates the importance of the physiological role of NKCC1 
in the peripheral auditory system [13].    
       There are both antagonists and agonists to NKCC1 that can alter its function and could 
serve as possible therapeutic agents. One such antagonist is bumetanide which is a diuretic and a 
specific blocker of NKCC1 [1, 14]. Bumetanide has approximately a 500-fold greater affinity to 
NKCC1, compared to potassium-chloride transport member 5 (KCC2) [15]. In some cellular 
assays, bumetanide in low concentrations (2-10µM) can inhibit NKCC1 and is an ideal tool to 
study NKCC1 physiological actions [15]. Aldosterone (ALD), a naturally occurring hormone, is 
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considered an agonist of NKCC1, and plays an important role in the maintenance of Na
+
, K
+
 and 
acid-base balance in renal systems [1]. In aging and many other disease conditions, decreases in 
NKCC1 activity or/and mis-regulation of Na
+
 and K
+ 
occurs [1].  
 
1.2 Motivation 
Previous work in our lab has shown that long-term systemic treatment of ALD has 
restored hearing in aging mice, probably by increasing stria sodium-potassium transport and up-
regulation of NKCC1 protein expression through mineralocorticoid receptors [1, 16]. This 
provides motivation for us to investigate the effects of ALD on NKCC1 and the underlying 
cellular and molecular events taking place. Our objective in using whole-cell patch clamp 
recordings is to study the electrical changes of NKCC1 and other ion channels following 
application of ALD and its antagonists. In the present investigation, we recorded whole-cell 
currents from SH-SY5Y cells, as these cells are derived from a neuronal cell line.  
 
1.3 Thesis Organization 
This thesis is comprised of four chapters. Chapter one provides an introduction to 
NKCC1 and its roles in the auditory system and motivation of this research. Chapter two 
describes the materials and methods used to carry out this research. Chapter three contains the 
results and discussion, accompanied by figures, and chapter four discusses the implication of our 
findings and describes future work.          
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CHAPTER 2: 
MATERIALS AND METHODS 
 
2.1 Reagents and Equipment 
Chemicals required for extracellular and intracellular solutions including NaCl, KCL, 
Glucose, MgCl2, CaCl2 and MgSO4 were obtained from Fischer Scientific Company, LLC 
(Pittsburg, PA). HEPES ((2-Hydroxyethyl) piperazine-1-ethanesulfonic acid sodium salt, N-(2-
Hydroxyethyl) piperazine-N′-(2-ethanesulfonic acid)), Adenosine 5’-triphosphate magnesium 
salt, EDTA were purchased from Sigma-Aldrich, Inc. (St. Louis, MO). DMEM, F12 reagents for 
cell culture were obtained from Gibco Life technologies, LLC (Carlsbad, CA) and the RT-PCR 
kit for protein expression was purchased from Invitrogen (Carlsbad, CA).  
     Instruments used in making extracellular and intracellular solutions were a Mettler 
Toledo balance for weighing chemicals, and Beckman ISE meter for pH measurements. A 
Thermo 1300 series A2 Biological safety cabinet, VWR Incubator and Nikon eclipse TS100 
microscopy were used for cell culture. Molecular devices (Molecular Devices, LLC. Sunnyvale, 
CA) supplied the patch clamp amplifier Multiclamp 700B, and the DMI 4000 phase contrast 
microscopy used to visualize the cells was performed with a Leica Microsystems (Leica 
Microsystems, Inc. Buffalo Grove, IL). Micromanipulators were obtained from Warner 
instruments, LLC. (Hamden, CT).  
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2.1.1 Patch Clamp Setup 
Patch clamp is one of the most highly sensitive and challenging techniques used in 
neuroscience, because of this it is crucial to follow standard procedures. Electrical and vibration 
interference are the two main variables to be considered in setting up a patch clamp system. 
These two parameters are crucial, because while performing experiments, significant noise can 
be introduced from electrical and vibrational interference [17]. To reduce electrical noise a 
Faraday cage was used to shield the setup from unwanted electrostatic discharges and electric 
fields. The microscope, pre-amplifiers and manipulators were placed inside the cage and all the 
devices were grounded. External vibrations were compensated by using a Micro-g anti-vibration 
table (model no 63-533, TMC, Peabody, MA) where the table top is mounted on a gas source 
(nitrogen tank). 
 
2.1.1.1 Microscope 
A Leica DMI 400B inverted microscope was used in our patch clamp system to visualize 
the cells at 5x, 10x, 20x, and 40x magnification. A condenser is present on the top of the 
recording chamber and the distance between the condenser and the recording chamber is crucial, 
as it allows enough space for the micropipette to access the recording chamber. A Nikon camera 
was connected to the microscope which is in turn connected to a computer which allows for 
capturing video and photos.       
 
2.1.1.2 Amplifiers 
Amplifiers included a measuring amplifier and clamping amplifier. Measuring amplifiers 
have an extension called the external probe and the recording electrode that makes contact with 
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the cell is connected to the probe through a pipette holder. The Multiclamp 700B amplifier 
receives data from the measuring amplifier and acquires the data via a Multiclamp software user 
interface. 
 
2.1.1.3 Manipulators 
Micromanipulators (Warner Instruments, Hamden, CT) placed inside the Faraday cage 
were used to move the probe precisely.  The primary function of the manipulators was to 
position the micropipettes near the cell.  
 
  2.1.1.4 Pipette Puller and Patch Pipettes  
Microelectrodes were fabricated on a Sutter Instruments model-97 pipette puller (Novato, 
CA) programmed with pressure, temperature and velocity parameters in order to get the desired 
pipette tip size and resultant resistance of 5-8 MΩ. Warner instrument glass electrodes were used 
to make patch pipettes and were prescreened under a microscope to select the desired shape. 
 
 
Figure 2.1: (a) Patch clamp system and its main components. (1) Pipette holder, (2) 
Manipulator, (3) Preamplifier, (4) Objective lens, (5) Condenser, (6) Recording chamber, (7) 
Microscope camera and (8) Manipulator controller. (b) Data Acquisition unit, DigiData 1440A. 
(c) Multiclamp 700B amplifier.    
3 
1 6 
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Figure 2.1: (Continued) 
 
2.2 Cell Culture  
SH-SY5Y (ATCC
®
 CRL-2266
™
) neuroblastoma cells were cultured in a medium 
containing a mixture of F12 & DMEM (1:1 v/v) supplemented with 1% Penicillin Streptomycin 
b 
c
b 
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(Pen Strep) and 10% FBS. The cells were then incubated in an incubator maintained at 37
o
C 
temperature, 5% CO2 and 95% humidity. Over the past four decades, only a little change 
occurred in normal cell culture conditions of SH-SY5Y [18]. The doubling time for parental 
populations was approximately 27 h and the medium was replaced after every 4-7 days. Cells 
were incubated with trypsin solution for 1-2 minutes to detach adherent cells. Cells with trypsin 
solution were combined with equal volume of F12 & DMEM (1:1 v/v) medium with 1% Pen 
Strep and 10% FBS added to it. The resultant solution was then centrifuged at 1500 rpm for 5 
min. The pellets were then suspended in F12 & DMEM (1:1 v/v) medium with 1% Pen Strep and 
10% FBS. The cells at this stage are undifferentiated and appear round and form clusters. 
Previously, it was reported that the undifferentiated cells lack mature neuronal markers and have 
the ability to proliferate continuously [18]. Morphologically, the undifferentiated cells were 
neuroblast-like with non-polarized cell bodies and few truncated processes.  
Differentiation of SH-SY5Y cells is achieved by adding retinoic acid (RA) to the cell 
culture medium. RA has known to possess cellular differentiation and growth inhibiting 
properties [19, 20]. Within 48h of plating, the serum-containing medium was replaced with 
neurobasal medium supplemented with B27 and GlutaMAX. To promote differentiation, 10µM 
all-trans-retinoic acid was added to the cell culture medium and the medium was replaced after 
every 48h. Differentiated cells were observed under the microscopy and were more pyramidal 
shaped, distributed, and had extended neurites (Figure 2.2). 
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Figure 2.2: SH-SY5Y cells observed under bright field microscopy (Nikon Eclipse) using 20x 
magnification. Top arrow displays undifferentiated (S-type) clumps of cells growing on top of 
one another and bottom arrow displays differentiated SH-SY5Y cells with extended neurites 
referred to as N-type cells.         
 
2.3 RT-PCR Experiments  
2.3.1 RNA Isolation 
Undifferentiated and differentiated SH-SY5Y cells total RNA was extracted according to 
the RNAeasy Mini kit (Qiagen, Inc. Valencia, CA) instructions. Initially, the cell culture medium 
was discarded completely and cells were lysed using a rubber policeman in the petri dishes by 
adding 350 µl of RLT buffer. The lysate was then homogenized for 30 s using a rotor-stator 
homogenizer. One volume of 70% ethanol was then added to lysate and mixed well using 
pipette. Contents were then transferred to RNeasy column and centrifuged at 10000 rpm for 15 s, 
and the flow through obtained was discarded. 350 µl of RW1 buffer was added to the RNeasy 
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column, followed by centrifugation for 15 s at 10000 rpm, with the flow through discarded. A 
mixture of 10 µl DNAase stock I solution with 70 µl of RDD buffer was prepared and then 
transferred to the RNeasy column membrane and placed on a benchtop for 15 min at a 
temperature of 26
o
C. In the next step, 350 µl of RW1 buffer was added to the RNeasy column, 
followed by centrifugation at 10000 rpm for 15 s and the flow through obtained was discarded.  
Then,  700 µl of RW1 buffer was added, followed by centrifugation for 15 s at 10000 rpm, with 
the flow through discarded. Then 500 µl of RPE buffer was added, followed by centrifugation 
for 15 s at 10000 rpm, and the flow through obtained discarded. The previous step was repeated 
with centrifugation duration extended to 2 min.  The RNeasy column was then placed in a 
collection tube and 30 µl of RNase free water added, followed by centrifugation for 1 min at 
10000 rpm. The final RNA yield is collected and used in the RT-PCR assay. 
 
2.3.2 RT-PCR  
Quantitative reverse-transcription-polymerase chain reaction was performed in a two-step 
approach: first qRT-PCR was done using Enhanced Avian HS RT-PCR-100 Kit (HSRT20; 
Sigma) and then Real-time PCR using SYBR Green PCR Master Mix (7900HT; Applied 
Biosystems, Carlsbad CA). RT-PCR was performed according to manufacturer’s procedure and 
primers set details are given in the table below. 
Table 2.1: Primer sequences and their details. 
 
Targets  Primer Sequence Product size (bp) 
RT-PCR 
NKCC1 S 5’-ACCTTCGGCCACAACACCATGGA-3’(S) 
184 kbp 
AS 5’-ACCACAGCATCTCTGGTTGGA-3’ (AS) 
S – Sense strand, AS- Antisense strand  
11 
 
Initially, semiquantitative qRT-PCR reaction was performed at 45
o
C for 50 min, and the 
reaction conditions were adjusted to eliminate competition between primer sets. The products 
obtained from primer reaction were then PCR amplified. First cycle conditions were 95
o
C for 
10min, 65
o
C for 45 s and 72
o
C for 1 min followed by 25 cycles at 95
o
C for 45 s, 65
o
C for 45 s, 
and 72
o
C for 1 min. Negative control was performed which included RNA instead of cDNA [1]. 
Using qRT-PCR products and SYBR Green PCR Master Mix, real-time RT-PCR mixture 
was prepared. The conditions for thermo cycling conditions were same as the semiquantitative 
reaction. In each PCR reaction negative and also positive samples were included. The expression 
of gene was referred to the β-actin mRNA content.       
 
2.4 Electrophysiological Recordings 
2.4.1 Preparation of Extracellular and Intracellular Solutions 
Standard extracellular solution (ECS) and intracellular solution (ICS) were prepared 
using the concentrations described in Table 2.2. Weight of each component was calculated using 
the concentration, molecular weight and final volume. All the contents were sterilized using an 
autoclave at 15 psi pressure, 121
o
C temperature for 20 min. To prevent degradation, glucose was 
added to ECS after sterilization. In preparation of ICS solution Mg ATP was added after 
autoclave sterilization. For ECS the pH was adjusted to 7.3 using NaOH and for ICS pH was 
adjusted to 7.4 using KOH.  
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Table 2.2: ECS & ICS components and their concentrations for SH-SY5Y cells. 
 
ECS ICS 
Components  Concentration (mM) Components  Concentration (mM) 
NaCl 125 KCl 140 
KCL 4 NaCl 4 
CaCl2 2 CaCl2 0.02 
MgSO2 1.2 EGTA 0.8 
Glucose 10 MgCl2 2 
HEPES 10 MgATP 4 
  HEPES 10 
 
2.4.2 Perfusion System  
A customized perfusion system was constructed to allow local application of drugs to 
cells and continuous exchange of ECS. Our perfusion system is comprised of syringe reservoirs, 
luer stopcocks, blunt-end needles, polyethylene tube (PE -160), and 4-1 manifold, all of them 
were purchased from Warner Instruments (Hamden, CT). The syringe reservoirs were positioned 
at a fixed height from the recording chamber using a retort stand through a 3D printed holder. 
Syringe openings are connected to luer stopcocks and the open end of luer stopcocks are 
connected to blunt end needles. PE tubing connects blunt end needles to manifold inputs and 
number of reservoirs should be equal to number of manifold inputs. A single tube exits the 
manifold and goes into the petri dish.  
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Figure 2.3: Schematic diagram representing various components of the gravity fed perfusion 
system. The system was comprised of syringe reservoirs, where different solutions can be loaded 
in each reservoir. The bottom ends of the syringes were connected to luer stopcocks, which were 
then connected to PE tubing through blunt needles. The other end of the PE tubes went into the 
manifold inlets, and the manifold outlet was connected to the perfusion chamber inlet through PE 
tube. The perfusion chamber outlet was then connected to the cell waste container through PE 
tubing.     
 
2.4.3 Micropipette  
For whole-cell recordings micropipettes were prepared using a Flame/brown micropipette 
puller (Model-97, Shutter Instruments Co. Novato, CA). Initially, fire polished Borosilicate 
Syringe 
Reservoirs  
Luer Stopcocks  
PE tubing  
Manifold inlet  
Manifold outlet 
Perfusion chamber 
Perfusion 
chamber outlet  
Cell waste  
 
Pipette  
Perfusion Chamber 
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glass pipettes were positioned in the pipette puller and pulling parameters (pressure, 
temperature, and velocity) were adjusted to achieve desired pipette resistance of 5-8 MΩ. The 
tip of the micropipette was then examined under Olympus BH2 upright microscopy (Olympus 
America, Inc., Center Valley, CA) to ensure it had a stubby tapered end. 
 
 
 
 
 
 
 
 
 
               
 
Figure 2.4: Optimal micropipette shape for whole cell recording, examined under Olympus BH2 
microscopy at 40x magnification. The inset is magnified and shown, (1) Pipette (2) Taper and (3) 
Tip.    
 
2.4.4 Whole Cell Recording 
Initially, the cell culture medium present in the petri dish is replaced with ECS and placed 
in the recording chamber. The chamber inlet and outlet are adjusted in such a way that the inlet 
groove is completely immersed in the ECS and the outlet is positioned at 45
o
 angle. The ground 
electrode was carefully placed in the dish ensuring that the electrode is continuously in contact 
with the ECS. ICS was used to fill up to three-fourth of micropipette and carefully inserting the 
 
1 
2 
3 
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Ag wire into the pipette, ensure the Ag wire is in contact with the ICS. Intracellular solution 
contained the following components (in mM): KCl 140; NaCl 4; CaCl2 0.02; EGTA (Ethylene 
glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid) 0.8; MgCl2 2; MgATP 4; HEPES 10; 
pH was adjusted to 7.4 with KOH [21]. Two reservoirs were fixed to perfusion system; one filled 
with ECS and the other filled with ECS+Bumetanide in initial experiments and ECS+ALD in 
later experiments. The extracellular recording solution for SH-SY5Y contained the following (in 
mM): NaCl 139; KCl 4; CaCl2 2; MgSO4 1.2; D-Glucose 10; HEPES ( 4-(2-Hydroxyethyl) 
piperazine-1-ethanesulfonic acid, N-(2-Hydroxyethyl) piperazine-N′-(2-ethanesulfonic acid)) 10 
and  pH was adjusted to 7.3 with NaOH [21]. ECS perfusion was initiated by turning on syringe 
reservoir’s stopcock and suction was applied to chamber outlet. Gravity aided in maintaining the 
continuous perfusion flow, and flowrate was controlled using a control valve.  
All the recordings were performed using whole-cell patch clamp configuration at room 
temperature (21±1) [22]. Clampex10.3 (Molecular Devices, LLC. Sunnyvale, CA) version of 
software was used for recording and acquisition, and Multiclamp software was used for 
stimulation. Micropipettes having resistance in the range of 5-8 MΩ were selected for recording. 
Pipette capacitance (Cp) was negated by performing capacitance compensation prior to gigaseal 
formation. First the pipette was placed against the cell membrane and a Gigaseal was achieved 
by applying a small suction. Further negative pressure led to whole-cell configuration causing 
rupture of cell membrane [23]. Once a neuron was isolated recordings were digitized at 50 kHz, 
low pass filtered at 5 kHz and an initial holding potential was set at -60 mV. In voltage clamp 
mode, the currents were recorded using a range of +30 mV to -60 mV holding potential at 
increments of 10 mV.  
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Baseline whole-cell recordings were done by perfusion of ECS (with no drugs) and then 
ECS containing 10µM bumetanide was applied to cells and whole cell currents were recorded. 
Finally recordings were acquired for washout by switching back to ECS. Recordings were 
carried out after every ~5 min from the control recording. The flow rate of the perfusion was 
kept consistent at a rate of 1 ml/min.  All the recordings i.e., control, bumetanide and washout 
were acquired from single cell each time. When switching to different solutions during 
recording, we ensured to keep the perfusion rate consistent. Similar experiments were conducted 
to study the effects of 0.1, 1 and 10 µM ALD on these cells and whole-cell current recordings 
were performed on several cells. Whole-cell currents had a sampling frequency of 10 KHz with 
an interval of 100 µs and low pass filtered at 1000 Hz using Gaussian type. These recordings 
were later analyzed by using I-V curves and raw patch clamp data.       
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CHAPTER 3: 
RESULTS AND DISCUSSION 
 
 
3.1 NKCC1 Co-transporter Expression in SH-SY5Y Cells  
  SH-SY5Y cell lines are known to express human-specific proteins and other protein 
isoforms [18]. To study NKCC1 gene expression in the SH-SY5Y cell line we performed a two-
step RT-PCR experiment. HT-29 cells served as the control, as other studies have shown 
NKCC1 existence and activity in these cell lines [1] [24]. The protein expression profile shown 
in Figure: 3.1 also indicates the presence of NKCC1 cotransporter in SH-SY5Y cells. Markers 
indicated that the NKCC1 target sequence falls in the 150-200 bp size range. Using NKCC1 
published sequences (NM_001046) and primers we found the amplified product length to be 184 
bp, covering base pairs from 799 – 983.  All four samples of SH-SY5Y cellular lysates showed a 
single band, of which two samples were from differentiated SH-SY5Y cells and other two from 
undifferentiated cells. Interestingly, both undifferentiated and differentiated cells showed the 
expression of NKCC1, as indicated by the bands in Figure 3.1. In sum, our findings suggest that 
SH-SY5Y neuroblastoma cells show the same level of NKCC1 expression in differentiated and 
undifferentiated states.    
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NKCC1 
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Figure 3.1: NKCC1 cotransporter is expressed in SH-SY5Y cells. Cellular lysates obtained 
from SH-SY5Y cells were analyzed using gel electrophoresis. Series of clear bands on left side 
are markers and single clear band on right side is control (HT-29 cells). NKCC1 co-transporter 
expression was detected at around 175 bp size in all four samples.  
                                                                 
 3.2 Bumetanide Increases K
+
 Currents in SH-SY5Y Cells 
Whole cell recordings were performed to determine the effect and function of bumetanide 
on NKCC1 cotransporter in SH-SY5Y cells. Whole-cell currents were recorded in voltage clamp 
mode with a series of depolarizing voltage steps from -60 mV to +30 mV using a 10 mV step 
size, for 300 ms of duration. 
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Figure 3.2: Bumetanide induced an increase in potassium currents of SH-SY5Y cells. (a) I-V 
curves of whole-cell voltage clamp recordings for control, bumetanide (10µM), and wash 
experiments from a single representative cell.  A shift in I-V currents is observed when 10 µM 
bumetanide is applied. The control and wash I-V curves had almost same current levels at 0 mV 
voltage, when compared with bumetanide currents. (b) Raw current traces of SH-SY5Y whole-
cell K
+ 
currents stimulated by 300 ms test pulses from -60 mV to +30 mV, in 10mV step 
increments.  
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  Outward K
+
 currents increased when 10 µM bumetanide was perfused for ~10 mins for 
whole-cell currents were recorded at -60 mV holding potential (Figure 3.2).  Following washout 
of bumetanide the outward K
+
 currents recovered to near control levels. So,the outward K
+
 
currents were reversibly increased by this NKCC1 blocker and 10 µM bumetanide concentration 
is shown to be effective in inhibiting NKCC1 activity [1]. Bumetanide activates K+ conductance 
as shown by increases in K
+
 currents, Figures  3.2b (Current traces from one representative cell) 
and 3.3 (Cumulative I-V curves for 21 cells). I-V curve from a single cell (Figure 3.2 (a)) 
indicates that a prominent increase in K
+
 currents was observed from 0 mV to 30 mV membrane 
potential range. 
The whole-cell currents had a sampling frequency of 10 KHz with an interval of 100 µs 
and low pass filtered at 1000 Hz using Gaussian type. As shown in Figure 3.2(b), onset of K 
currents for depolarization test potentials ranging from -60 mV to +30 mV from a holding 
potential of -60 mV.    The I-V curve from a single, representative cell (Figure 3.2 (a)) shows 
that a prominent increase in K currents was observed for the 0 - 30mV potential range.  
As shown in Figure 3.3, the outward potassium currents increased when bumetanide was 
applied. There was a significant difference in mean values (P=0.0041, n=8) when the paired 
Students t-test was performed. Using Clampfit, the current values for corresponding voltage for 
each cell are noted for control, bumetanide and wash. The mean±SEM curves were then plotted.  
 
 
 
21 
 
-8 0 -7 0 -6 0 -5 0 -4 0 -3 0 -2 0 -1 0 1 0 2 0 3 0 4 0
-1 0 0
1 0 0
2 0 0
3 0 0
C o n tro l
B u m e ta n id e
W a s h
(p A )
 (m V )
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3: I-V curves of SH-SY5Y whole cell recordings (n=8), representing mean current-
voltage relations. Current and voltage values were plotted in GraphPad Prism using the data from 
Clampfit software. At each cell holding potential, mean currents, ±SEM, are displayed for 
control, bumetanide and wash curves.  These data indicate a two-fold increase in potassium 
currents for bumetanide application when compared to the control. Potassium currents decreased 
relative to bumetanide for the wash recordings.  
 
3.3 Sensitivity of K
+
 Channels to ALD  
           In order to study the effects of ALD on NKCC1 channels, ECS containing 1 µM ALD 
was perfused and whole-cell recordings were performed. These recordings were made with 
continuous perfusion of ECS, and a change in K
+
 outward currents was observed after ̴ 10 min of 
ALD application. A single-cell data analysis indicated that there is a reversible increase in 
outward K currents in response to 1 µM ALD, and further washout of ALD for ̴ 15 min revealed 
recovered  current amplitudes. As shown in Figure 3.4(a), I-V relationship curve of a single cell 
shows the prominent increase in current at -10 – 30 mV holding potentials.               
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Figure 3.4: Potassium channels in SH-SY5Y cells are sensitive to ALD. (a) I-V curves of whole-
cell voltage clamp recordings for control (blue), ALD (red), and wash (black) experiments from 
a single cell.  A shift in I-V currents is observed when 1 µM ALD was applied to cells. The 
control and wash I-V curves had almost same current levels at 0 mV voltage, when compared 
with ALD curve. (b) Current traces of SH-SY5Y whole-cell K
+ 
currents stimulated by 300 ms 
test pulses from -60 mV to +30 mV holding potentials, in 10mV step increments. 
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 As shown in Figure 3.5, at positive membrane potential, a prominent shift in I-V curves 
was observed with application of ALD. I/V curves with mean ±SEM from 21 cells provide 
strong evidence supporting an increase in K
+ 
currents in SH-SY5Y cells. A paired Student t-test 
suggest that there is a significant difference (P=0.0027, n=21) between mean values of control 
and ALD values. The data in Figure 3.5a indicate that the significant onset of the response to 
ALD was above -30 mv membrane potential, and I-V curve shifted further with additional 
increases in the membrane potential. K
+
 current traces analyzed for single cells when stepping to 
+30 mV indicate the increases in currents before and after ALD application range from 90.28 pA 
to 216.70 pA at 50 ms point, as presented in Figure 3.5b.      
 
Figure 3.5: K
+
 current amplitudes in response to ALD at different cell holding potentials. (a) 
Mean (n=21) current values plotted across -60 to +30 mV holding potentials  show the increase 
in outward K
+
 currents with increases in potential. (b) Single-cell analysis characteristic of K
+ 
current traces for +30 mV; increases in K
+ 
currents are clearly observed with application of 1 µM 
ALD.    
 
 
-6
0
-5
0
-4
0
-3
0
-2
0
-1
0 0
1
0
2
0
3
0
0
5 0
1 0 0
1 5 0
2 0 0
C o n tro l
A L D
W a s h
(p A )
 (m V ) T im e  (s )
C
u
r
r
e
n
t
 
(
p
A
)
0 .0 0 0 .0 5 0 .1 0
0
1 0 0
2 0 0
3 0 0
A L D
C o n tro l
(a) (b) 
24 
 
-8 0 -7 0 -6 0 -5 0 -4 0 -3 0 -2 0 -1 0 1 0 2 0 3 0 4 0
-5 0
5 0
1 0 0
1 5 0
2 0 0
C o n tro l
A L D
W a s h
(p A )
 (m V )
 
 
Figure 3.6: I-V curves of SH-SY5Y whole cell recordings (P<0.05, n=21), representing mean 
current-voltage relations. Current and voltage values were plotted in GraphPad Prism using the 
data from Clampfit software. At each potential, mean ±SEM is displayed for control (blue), ALD 
(red) and wash (black) curve.  The curves indicate an increase in potassium currents for ALD 
when compared to controls and washout recordings. 
 
Apart from 1 µM ALD concentration, experiments with 0.1 and 10 µM were also 
performed and these concentrations resulted in similar I-V trends.  
 
3.4 Discussion 
To our knowledge this is the first time the regulatory effects of the hormone ALD have 
been measured on K
+
 channel currents in SH-SY5Y cells. ALD has the ability to upregulate 
NKCC1 protein expression, linking it to a possible therapeutic targets for improving age-related 
changes in cochlear physiology [1]. Ding and colleagues first showed that ALD’s action on 
NKCC1 works through mineralocorticoid receptors and related mechanisms, including protein 
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stabilization [1]. However, the biophysical mechanisms underlying the action of ALD in in vitro 
is not yet known and our initial investigations provide increased understanding of physiological 
responses of SH-SY5Y cells to ALD. In our initial studies, RT-PCR expression experiments 
confirmed the presence of NKCC1 co-transporter expression in SH-SY5Y cells. During 
differentiation of SH-SY5Y cells some unique properties might contribute towards development 
of different types of channels, such as expression of different channel subunits [21][26]. 
Interestingly, our findings indicated that both undifferentiated and differentiated SH-SY5Y cells 
show NKCC1 co-transporter expression. A similar analysis performed by Spitzner et al. 
illustrates the same expression levels of NKCC1 in differentiated and undifferentiated colon 
epithelium cells during tumorigenesis [25]. 
We first investigated the effect of the NKCC1 antagonist bumetanide on SHSY-5Y cells, 
in order to study the in vitro physiological response of the co-transporter. Bumetanide is known 
to inhibit NKCC1 activity, thereby causing a reduction of intracellular Cl
-
 concentration [27]. 
Whole cell recordings in the presence of 10 µM bumetanide showed a significant increase of K
+
 
currents (from 104.93 ± 30.15 to 213.25 ± 40.15 pA at +30 mV, n=8 before and after application 
of bumetanide). In agreement with our observations, Wang et al. demonstrated that loop diuretics 
like bumetanide activate intermediate conductances for Ca
+2
-activated K
+
-channels (IK) and also 
inhibit NKCC1 co-transporter [27]. There are additional findings that these SH-SY5Y cells lack 
KATP channels and that KATP does not contribute to outward K
+
 currents [28, 29]. We believe that 
the observed increase in K
+
 currents with bumetanide application is through activation of 
voltage-gated K
+
 channel and IK channels [28, 30].  
SH-SY5Y whole cell current measurements following application of  bumetanide provide 
further indication that NKCC1 might be interacting with the blocker.  Molecular studies by Ding 
26 
 
et al. found that ALD sensitively regulates NKCC1 protein expression [1]. Whole-cell current 
recordings from SH-SY5Y cells in the presence of 1µM ALD showed an outward increase in K
+
 
currents similar to bumetanide response (from 100.28 ± 12.06 to 148.82 ± 19.17 pA at +30 mV, 
n=21 before and after application of ALD). A comparison between the mean values of 
bumetanide and ALD reveals that increases in whole cell currents with bumetanide are higher 
compared to increases due to ALD (Refer Table 3.1).     
Table 3.1: Comparison of mean current values of bumetanide and ALD. 
Voltage (mV) Control (Mean current values) Drug (Mean current values) 
Bumetanide (pA) 
n=8 
ALD (pA) 
n=21 
Bumetanide (pA) 
n=8 
ALD (pA) 
n=21 
-60 -36.93 -21.67 -44.76 -20.01 
-50 -28.62 -15.5 -28.94 -13.91 
-40 -19.4 -9.25 -8.61 -4.95 
-30 -7.12 -2.43 18.4 9.81 
-20 5.6 7.64 51.29 31.65 
-10 23.96 21.69 86.85 62.53 
0 44.23 44.31 120.21 95.75 
10 65.18 70.15 151.66 121.76 
20 87.95 89.51 179.5 138.7 
30 104.93 100.28 213.25 148.82 
   Drug = Bumetanide / ALD, n = number of cells 
In marginal cells of the cochlear stria vascularis which produce endolymph, NKCC1 is 
known to be involved in synergistic transport of K
+
 ions into the cochlear duct [31]. 
Interestingly, our findings from whole-cell current recordings suggest that ALD increases K
+
 
currents in SH-SY5Y cells. It is also reported that ALD regulates K
+
 channels in other 
physiological systems such as in the lungs,  where the hormone ALD has been shown to regulate 
K
+
 channels in the alveolar epithelium [32]. It is also known that ALD increases the basolateral 
Na
+
, K
+
-ATPase total activity in renal systems [33]. Our initial data presented in this Thesis 
reveals additional role of ALD in K
+
 currents in neural cells, and further experiments could 
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provide a better understanding about the effects of ALD on NKCC1 and K
+
 channels. Taken 
together, our studies implicate that bumetanide and ALD regulate K
+
 channel currents in human 
neuroblastoma cells. Identification of specific NKCC1 single channel responses using inside-out 
patch clamp methodology, that allows for single NKCC1 channels to be isolated, will be a major 
challenge, since there is need for more evidence on direct measurement of NKCC1 currents.       
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CHAPTER 4 
CONCLUSION 
 
4.1 Summary 
We demonstrated for the first time that the NKCC1 ion channels are expressed in both 
undifferentiated and differentiated SH-SY5Y cells using RT-PCR gene expression techniques. 
Once we confirmed the presence of NKCC1 in these cells,   electrophysiology experiments were 
conducted to study the actions of bumetanide and ALD on the SH-SY5Y cell physiology. 
Whole-cell current recordings in the presence of 10 µM bumetanide indicate that this NKCC1 
antagonist always induced an increase in outward K
+
 currents in this cell line.  Apart from 
bumetanide studies, we discovered that ALD helps regulate K
+
 channel currents in SH-SY5Y 
neuroblastoma cells. Whole-cell current data obtained from SH-SY5Y cells when treated with 1 
µM ALD reveal this hormone’s ability to increase the K+ channel currents. At this point the 
exact sequence of events and the intermediate compounds acting in this physiological response 
are yet to be delineated in more detail. But previous findings in other cells suggest that ALD can 
regulate K
+
 and other channels with different functional effects [32, 33]. Furthermore, 
bumetanide, being a specific NKCC1 blocker, may increase  K
+
 currents related to NKCC1. On 
the other hand, regarding ALD regulatory actions on K
+
 channel currents, further experiments 
could provide a definite understanding of its physiological mechanism of action on NKCC1, and 
further our knowledge of roles in hearing loss, including ARHL. 
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4.2 Future Work  
We intend to continue our work in investigating the effects of ALD on NKCC1 in vitro, 
to further understand the mechanisms underlying K
+
 currents in neural action potential 
generation. A logical next experiment is to perform siRNA silencing of NKCC1 expression in 
SH-SY5Y cells and then study the ALD responses. These experiments can provide crucial 
information on exactly how ALD is acting on NKCC1 channel activity or other cell membrane 
ion channels crucial for key physiological functions.   
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                                                           APPENDIX A: 
I-V CURVES OF WHOLE CELL CURRENT RECORDINGS  
 
A.1 Whole Cell Currents Recordings and I-V Curves 
  
 
 
Figure A.1: Representative I-V curve analysis of whole cell current recordings shown in 
Clampfit. 
 
Figure A.2: Representative whole cell currents recording shown in Clampfit.
Quick I-V
Control
Bumetanide
Wash
Cmd 0 at Cursor 1 (mV)
-60 -50 -40 -30 -20 -10 10 20 30
IN
 0
 M
e
a
n
 (p
A
)100
200
34 
 
Quick I-V
Cell 1 
Cell 2
Cell 3
Cell 4
Cell 5
Cell 6
Cell 7
Cell 8
Cmd 0 at Cursor 1 (mV)
-80 -60 -40 -20 20 40 60 80
IN
 0
 M
e
a
n
 (p
A
)
200
400
 
 
 
 
 
 
 
 
 
 
Figure A.3: I-V curves of control whole cell current recordings (n=8). 
 
 
 
 
Figure A.4: I-V curves of whole cell current recordings when bumetanide is applied (n=8). 
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Figure A.5: Mean I-V curves of Bumetanide (n=8) and ALD (n=21) whole cell current 
recordings. 
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APPENDIX B: 
WHOLE CELL CURRENT RECORDINGS DATA 
 
Table B.1: Current values (pA) recorded at different voltages (mV) before bumetanide 
application. 
 
Voltage 
(mV) 
Current (pA) 
Cell1 Cell 2 Cell 3 Cell 4 Cell 5 Cell 6 Cell 7 Cell 8 
-60 -26.8 -70.9 -5.2 -36.1 -40.7 -58.8 -40.3 -16.8 
-50 -22.2 -52.8 -3.4 -23.9 -30.7 -48.3 -34.4 -13.1 
-40 -10.9 -32.6 -2.0 -14.9 -20.4 -38.4 -30.1 -6.5 
-30 7.9 -15.3 5.6 -2.5 -7.5 -19.6 -25.5 0.0 
-20 19.0 0.1 11.4 15.4 13.3 -2.2 -21.2 9.3 
-10 44.4 18.9 17.7 46.9 49.7 9.3 -17.2 22.0 
0 66.1 38.3 24.7 77.4 95.9 24.4 -13.7 40.8 
10 79.5 57.0 32.4 140.8 133.3 39.4 -7.4 46.6 
20 92.6 84.9 35.3 221.6 161.7 56.7 4.6 46.2 
30 96.4 112.1 35.3 269.2 189.9 70.8 22.7 42.9 
 
Table B.2: Current values (pA) recorded at different voltages (mV) after bumetanide (10 µM) 
application. 
 
 
 
 
 
 
 
 
 
Voltage 
(mV) 
Current (pA) 
Cell1 Cell 2 Cell 3 Cell 4 Cell 5 Cell 6 Cell 7 Cell 8 
-60 -22.4 -158.6 -46.1 -30.0 -30.9 -56.8 -11.1 -2.3 
-50 -16.5 -113.5 -17.4 -13.4 -25.8 -41.7 -8.6 5.5 
-40 -4.3 -73.0 10.2 29.8 -17.8 -20.0 -6.3 12.6 
-30 12.1 -36.9 38.8 87.9 8.4 16.3 -1.8 23.0 
-20 42.7 -1.5 69.3 172.1 40.8 38.0 6.1 43.0 
-10 81.4 34.5 101.2 222.1 96.3 66.4 20.3 72.6 
0 124.9 66.6 133.2 243.6 159.2 121.3 38.4 74.5 
10 146.3 101.7 167.5 260.5 203.8 203.1 60.3 70.1 
20 155.2 139.9 202.8 263.3 228.8 301.1 75.0 70.0 
30 159.2 207.5 238.6 273.0 246.8 425.2 87.4 68.3 
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Table B.3: Current values (pA) recorded at different voltages (mV) before ALD 
application. 
 
Voltage 
(mV) 
Current (pA) 
Cell1 Cell 2 Cell 3 Cell 4 Cell 5 
Cell 
6 
Cell 
7 
Cell 
8 
Cell 
9 
Cell 
10 
Cell 
11 
Cell 
12 
Cell 
13 
Cell 
14 
Cell 
15 
Cell 
16 
Cell 
17 
Cell 
18 
Cell 
19 
Cell 
20  
Cell 
21 
-60 11.0 -45.1 -37.5 -32.0 -26.6 -34.1 -40.3 -16.8 0.0 -2.5 -21.6 -10.8 -7.4 -34.1 -59.3 -7.6 -7.7 -18.9 -1.0 -15.2 -47.7 
-50 16.3 -29.6 -29.8 -25.3 -20.2 -24.3 -34.4 -13.1 3.2 0.0 -14.9 -5.7 -4.1 -24.1 -46.8 -5.0 -6.7 -13.6 -0.8 -10.0 -36.4 
-40 19.8 -14.0 -24.1 -16.9 -13.9 -14.0 -30.1 -6.5 6.3 2.8 -7.2 -2.1 -1.4 -16.3 -37.0 -0.8 -3.6 -9.3 0.5 -5.4 -21.3 
-30 24.1 4.0 -16.3 -4.0 -6.3 -4.9 -25.5 0.0 10.5 6.3 -0.3 2.5 1.4 -6.8 -26.9 3.5 -1.0 -4.7 4.7 -0.2 -11.3 
-20 30.4 33.2 -7.1 17.0 5.7 6.3 -21.2 9.3 22.0 11.9 10.8 11.5 5.0 9.6 -15.4 7.0 2.1 -0.3 9.3 6.1 7.4 
-10 33.1 62.5 9.8 41.9 20.4 15.8 -17.2 22.0 36.0 18.4 26.3 26.5 8.3 49.4 -1.4 10.4 12.9 5.1 27.8 22.1 25.4 
0 35.3 76.1 43.9 92.0 49.7 26.8 -13.7 40.8 60.9 32.9 57.5 64.0 10.6 104.5 14.3 14.5 46.7 17.3 55.2 52.8 48.7 
10 42.3 94.3 83.5 154.9 95.0 33.2 -7.4 46.6 72.6 70.7 106.2 101.2 13.6 115.1 28.7 21.6 101.1 55.0 91.4 79.1 74.4 
20 49.6 122.9 113.3 190.5 144.2 41.7 4.6 46.2 78.0 96.5 144.3 105.5 16.4 117.3 35.6 24.8 125.8 114.1 125.1 86.0 97.2 
30 53.0 138.0 143.6 211.1 183.1 50.9 22.7 42.9 78.7 106.8 171.0 111.6 18.4 107.0 45.0 27.4 126.8 139.7 138.1 84.7 105.6 
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Table B.4: Current values (pA) recorded at different voltages (mV) after ALD (1 µM) application. 
 
Voltage 
(mV) 
Current (pA) 
Cell1 Cell 2 Cell 3 Cell 4 Cell 5 Cell 6 
Cell 
7 
Cell 
8 
Cell 
9 
Cell 
10 
Cell 
11 
Cell 
12 
Cell 
13 
Cell 
14 
Cell 
15 
Cell 
16 
Cell 
17 
Cell 
18 
Cell 
19 
Cell 
20 
Cell 
21 
-60 -26.6 -74.9 -40.4 -22.0 -4.1 -2.2 -6.1 -2.3 -1.2 -10.6 -16.3 -21.7 -17.2 -20.8 -29.0 -4.0 -12.5 -24.7 -16.6 -7.3 -59.9 
-50 -19.7 -47.1 -29.8 -16.3 4.8 0.4 -3.6 5.5 -0.1 -7.5 -13.3 -17.5 -13.9 -14.3 -22.7 -0.7 -9.0 -20.4 -14.4 -5.3 -47.3 
-40 -7.2 -16.1 -19.8 -10.8 21.9 9.2 1.0 12.6 4.6 1.4 -8.0 -7.2 -8.4 -2.5 -16.5 3.9 -6.0 -16.4 -11.9 -2.1 -25.6 
-30 17.9 24.0 -11.3 9.6 52.8 16.6 10.0 23.0 9.0 19.0 16.7 0.4 0.6 23.0 -7.5 17.6 4.5 -10.6 -7.4 10.7 -12.3 
-20 75.2 65.4 0.3 38.0 99.2 32.4 25.4 43.0 20.7 38.1 52.5 6.4 14.2 44.3 14.6 24.9 23.1 6.2 -1.5 26.2 16.2 
-10 135.5 109.6 26.8 90.2 134.6 56.3 40.6 72.6 37.0 80.7 91.3 10.0 42.8 95.0 39.0 56.3 71.2 26.1 13.4 48.7 35.8 
0 164.8 153.0 70.6 208.8 156.9 63.5 57.4 74.5 52.6 149.6 140.7 16.9 63.7 131.8 63.7 77.2 131.5 64.6 37.9 83.3 47.5 
10 168.1 200.0 111.6 322.5 162.5 58.8 68.2 70.1 53.0 196.1 181.4 25.9 68.3 142.1 105.0 84.0 185.6 144.9 51.9 103.1 54.0 
20 176.5 254.4 146.4 336.9 175.2 57.3 78.7 70.0 56.0 215.0 199.4 45.0 75.7 125.5 141.0 89.0 195.0 237.0 69.0 102.8 66.9 
30 179.5 300.9 167.7 345.1 191.8 53.8 81.5 68.3 55.6 232.1 204.1 66.8 78.4 119.7 144.9 93.8 196.0 291.7 79.3 99.7 74.4 
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APPENDIX C: 
CUMULATIVE DATA GRAPHS 
 
 
 
 
 
 
 
 
 
 
Figure C.1: Cumulative (n=8) grouped graph for control, bumetanide and wash data.  
 
